ClinicalTrials.Veeva

Menu

Boswellia Serrata Extract in Acute Diarrhea

A

Azienda di Servizi alla Persona di Pavia

Status

Completed

Conditions

Acute Diarrhea
Boswellia Serrata

Treatments

Dietary Supplement: lecithin-based delivery form of Boswellia serrata
Combination Product: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT05345028
4806/11012022

Details and patient eligibility

About

Acute diarrhea is a frequent problem worldwide, mostly due to gastrointestinal infections or food poisoning. Boswellia serrata could be active in the treatment of acute diarrhea due to its an-ti-inflammatory, antispasmodic and antimicrobial activity.

Enrollment

49 patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • presence of acute diarrhea of mild to moderate severity

Exclusion criteria

  • patients with long term diarrhea
  • iatrogenic diarrhea
  • symptoms of functional gut disease or severe inter-current diseases
  • severe diarrhea and dehydration requiring hospitalization and intravenous treatment
  • subjects with high temperature (> 38.5° C)
  • subjects treated by other anti-diarrheal and antibiotic drugs in the last 24 hours
  • severely malnourished subjects
  • pregnant women

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

49 participants in 2 patient groups, including a placebo group

Boswellia Phytosome
Active Comparator group
Treatment:
Dietary Supplement: lecithin-based delivery form of Boswellia serrata
Placebo
Placebo Comparator group
Treatment:
Combination Product: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems